BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30095598)

  • 1. Molecular profiling of Spitz nevi identified by digital RNA counting.
    Hillen LM; Geybels MS; Rennspiess D; Spassova I; Ritter C; Becker JC; Garmyn M; Zur Hausen A; Van den Oord J; Winnepenninckx V
    Melanoma Res; 2018 Dec; 28(6):510-520. PubMed ID: 30095598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms.
    Hillen LM; Geybels MS; Spassova I; Becker JC; Gambichler T; Garmyn M; Zur Hausen A; van den Oord J; Winnepenninckx V
    FEBS Open Bio; 2020 Jul; 10(7):1326-1341. PubMed ID: 32431053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
    Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
    J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal spitz nevi: a rare subtype of spitz nevi analyzed in a clinicopathologic study of 74 cases.
    Plaza JA; De Stefano D; Suster S; Prieto VG; Kacerovska D; Michal M; Sangueza M; Kazakov DV
    Am J Dermatopathol; 2014 Apr; 36(4):283-94; quiz 295-7. PubMed ID: 24736667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiomatoid and desmoplastic Spitz nevus presenting as a keloidal nodule.
    Yu J; Jen MV; Yan AC; Elenitsas R; Rubin AI
    Pediatr Dermatol; 2018 Jul; 35(4):e228-e230. PubMed ID: 29582459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of Spitz Nevi.
    Emiroglu N; Yıldız P; Biyik Ozkaya D; Bahalı AG; Su O; Onsun N
    Pediatr Dermatol; 2017 Jul; 34(4):438-445. PubMed ID: 28664989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi.
    Maitra A; Gazdar AF; Moore TO; Moore AY
    Hum Pathol; 2002 Feb; 33(2):191-7. PubMed ID: 11957144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma.
    Kraft S; Moore JB; Muzikansky A; Scott KL; Duncan LM
    J Cutan Pathol; 2017 Oct; 44(10):843-850. PubMed ID: 28657121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
    King MS; Porchia SJ; Hiatt KM
    J Cutan Pathol; 2007 Jul; 34(7):576-80. PubMed ID: 17576338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
    Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
    J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problematic lesions in children.
    Moscarella E; Piccolo V; Argenziano G; Lallas A; Longo C; Castagnetti F; Pizzigoni S; Zalaudek I
    Dermatol Clin; 2013 Oct; 31(4):535-47, vii. PubMed ID: 24075543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus.
    Sarin KY; Sun BK; Bangs CD; Cherry A; Swetter SM; Kim J; Khavari PA
    JAMA Dermatol; 2013 Sep; 149(9):1077-81. PubMed ID: 23884457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of RAS-RAF-activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions.
    Indsto JO; Kumar S; Wang L; Crotty KA; Arbuckle SM; Mann GJ
    J Cutan Pathol; 2007 Jun; 34(6):448-55. PubMed ID: 17518771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic and atypical Spitz nevi: review of the literature.
    Sulit DJ; Guardiano RA; Krivda S
    Cutis; 2007 Feb; 79(2):141-6. PubMed ID: 17388217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spitz nevus versus malignant melanoma: spitz nevi predominate on the thighs in patients younger than 40 years of age, melanomas on the trunk in patients 40 years of age or older.
    Schmoeckel C; Wildi G; Schäfer T
    J Am Acad Dermatol; 2007 May; 56(5):753-8. PubMed ID: 17261342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silhouette symmetry: an unsupportable histologic criterion for distinguishing Spitz nevi and compound nevi from malignant melanoma.
    Okun MR
    Arch Pathol Lab Med; 1997 Jan; 121(1):48-53. PubMed ID: 9111092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.